Spectranetics Corporation
96 Talamine Court
Colorado Springs
Colorado
80907
United States
Tel: 1-800-633-0960
Fax: 719-633-2248
Website: http://www.spectranetics.com/
233 articles about Spectranetics Corporation
-
VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
3/9/2019
VIVA Physicians announced the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease in the superficial femoral artery.
-
Royal Philips Electronics N.V.'s Spectranetics Recalls Bridge Occlusion Balloon
8/31/2017
-
Spectranetics Announces Fundamental Change, Make-Whole Adjustment Event, Share Exchange Event And Supplemental Indenture For 2.625% Convertible Senior Notes Due 2034
8/11/2017
-
Spectranetics Reports Second Quarter 2017 Revenue Of $74.7 Million
8/4/2017
-
Spectranetics Secures FDA Approval of Stellarex Drug-Coated Balloon
7/27/2017
-
Spectranetics Announces Second Quarter Earnings Release Date
7/14/2017
-
Royal Philips Electronics N.V. Slams Down $2.16 Billion for Spectranetics
6/28/2017
-
Spectranetics Shows Off 100% Survival Rate in Bridge Occlusion Balloon Study
5/15/2017
-
Spectranetics Nabs CE Mark for Stellarex 0.014” Drug-Coated Balloon
11/22/2016
-
Second Interim Analysis On ILLUMENATE Global Study Presented On Spectranetics’ Stellarex Drug-Coated Balloon At NCVH
6/2/2016
-
QT Vascular Announces Another Positive Outcome In Litigation With Spectranetics/AngioScore, Inc.
2/11/2016
-
Spectranetics Announces FDA Submission Of Bridge Occlusion Balloon For Lead Extraction Procedures
12/9/2015
-
Spectranetics Announces Debt Financing
12/8/2015
-
Spectranetics To Present At The 27th Annual Piper Jaffray Healthcare Conference
11/18/2015
-
Spectranetics Wins FDA Approval of Turbo-Power Laser Atherectomy Catheter
11/13/2015
-
Spectranetics To Participate In Upcoming Investor Conferences
11/5/2015
-
Spectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million
10/22/2015
-
Spectranetics To Hold 2015 Third Quarter Financial Results Conference Call On October 22, 2015
10/8/2015
-
Spectranetics Names Stacy McMahan Chief Financial Officer
8/28/2015
-
Spectranetics To Present At The Canaccord Genuity Growth Conference
7/31/2015